🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Delusional Disorder

The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care NCT06005766NA1 site📍 Vaasa University of Jyvaskyla · Tests: Metacognitive Skills Training (MCT), Treatment as usual Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study NCT06692530n/a1 site📍 Balkbrug University Medical Center Groningen Enhancing Veteran-Clinical Collaboration in VA PRRCs NCT06898879NA3 sites📍 San Diego📍 West Los Angeles📍 Albuquerque VA Office of Research and Development · Tests: Collaborative Decision Skills Training, Leveling Up ACP-204 in Adults With Alzheimer's Disease Psychosis NCT06159673Phase 2, Phase 3154 sites📍 Chandler📍 Scottsdale📍 Anaheim ACADIA Pharmaceuticals Inc. · Tests: ACP-204, Placebo Feeling Safe Study NCT07234708NA1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Sentirnos Seguros Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy NCT06835556NA1 site📍 Nashville Vanderbilt University Medical Center · Tests: Cognitive Behavioral Therapy, TAU Immune Mechanisms of Antipsychotic Treatment Response NCT06687694n/a1 site📍 London King's College London A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis NCT06887192Phase 262 sites📍 Phoenix📍 Scottsdale📍 Tucson MapLight Therapeutics · Tests: ML-007C-MA, Placebo Tau Networks in Psychotic Alzheimer's Disease NCT05847192n/a1 site📍 Manhasset Northwell Health · Tests: [18F]-PI2620 PET scan Comparing Antipsychotic Medications in LBD Over Time NCT05590637Phase 42 sites📍 San Antonio📍 San Antonio The University of Texas Health Science Center at San Antonio · Tests: Pimavanserin, Quetiapine Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services NCT06740383n/a6 sites📍 Hartford📍 Athens📍 Chicago Beth Israel Deaconess Medical Center Tau Biomarkers in Late-onset Psychosis (LOP) NCT06336382n/a1 site📍 Manhasset Jeremy Koppel · Tests: Tau PET imaging scan FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis NCT07645443NA8 sites📍 Mannheim📍 Augsburg📍 München Stephanie Mehl · Tests: FEEL GOOD, Treatment as Usual (TAU)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy